Amicus Therapeutics, Inc. (FOLD)

NASDAQ

$10.89

+$0.34 (3.22%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$10.50$11.14

Open $10.50

52 Week Range

$5.51$11.14

Previous Close $10.55

Market Cap3.36B

Volume12.24M

Avg Volume5.18M

P/E (TTM)169.02

EPS (TTM)$0.06

Dividend / YieldN/A

Dividend StreakN/A

Analyst Ratings & Targets

Price Target

Consensus Target

$14.00

Based on 1 analyst (last year)

High Target

$14.00

Low Target

$14.00

Potential upside of 28.56%

Based on consensus price target

Price Target Timeframes

Last Month

$0.00

0 analysts

Last Quarter

$14.00

1 analysts

Last Year

$14.00

1 analysts

All Time

$15.83

6 analysts

Analyst Consensus

Current Consensus

Buy

Based on 22 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

B-

(Score: 3)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows4/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity4/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits4/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity1/5

P/EPrice to Earnings - Ratio of share price to company's earnings per share1/5

P/BPrice to Book - Ratio comparing market price to company's book value per share1/5

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Sep 18, 2025	Unknown	Needham	$14.00	$8.31	+68.47%
Oct 17, 2024	Tazeen Ahmad	Bank of America Securities	$15.00	$12.03	+24.69%
May 14, 2024	Debjit Chattopadhyay	Guggenheim	$13.00	$9.04	+43.81%
May 9, 2024	Jeffrey Hung	Morgan Stanley	$19.00	$9.48

Recent Analyst Actions


Nov 6, 2025	Maintained	JP Morgan	Overweight	Overweight
Nov 5, 2025	Maintained	Goldman Sachs	Neutral	Neutral
Sep 18, 2025	Upgrade	Needham	Hold	Buy
Jul 17, 2025	Upgrade	Morgan Stanley	Equal Weight	Overweight
May 2, 2025	Maintained	Goldman Sachs	Neutral	Neutral

Showing 1 to 5 of 119 entries

Analyst Ratings & Targets

Price Target

Consensus Target

$14.00

Based on 1 analyst (last year)

High Target

$14.00

Low Target

$14.00

Potential upside of 28.56%

Based on consensus price target

Price Target Timeframes

Last Month

$0.00

0 analysts

Last Quarter

$14.00

1 analysts

Last Year

$14.00

1 analysts

All Time

$15.83

6 analysts

Analyst Consensus

Current Consensus

Buy

Based on 22 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

B-

(Score: 3)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows4/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity4/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits4/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity1/5

P/EPrice to Earnings - Ratio of share price to company's earnings per share1/5

P/BPrice to Book - Ratio comparing market price to company's book value per share1/5

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Sep 18, 2025	Unknown	Needham	$14.00	$8.31	+68.47%
Oct 17, 2024	Tazeen Ahmad	Bank of America Securities	$15.00	$12.03	+24.69%
May 14, 2024	Debjit Chattopadhyay	Guggenheim	$13.00	$9.04	+43.81%
May 9, 2024	Jeffrey Hung	Morgan Stanley	$19.00	$9.48

Recent Analyst Actions


Nov 6, 2025	Maintained	JP Morgan	Overweight	Overweight
Nov 5, 2025	Maintained	Goldman Sachs	Neutral	Neutral
Sep 18, 2025	Upgrade	Needham	Hold	Buy
Jul 17, 2025	Upgrade	Morgan Stanley	Equal Weight	Overweight
May 2, 2025	Maintained	Goldman Sachs	Neutral	Neutral

Showing 1 to 5 of 119 entries